Experimental pill tested to fight aggressive Fat-Cell cancer
NCT ID NCT05496569
Summary
This study tested an oral capsule called TQB3616 against a placebo in adults with advanced dedifferentiated liposarcoma, a rare and aggressive cancer. The main goal was to see if the drug could delay cancer growth or extend life. The trial was stopped early after enrolling 26 of a planned 118 participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEDIFFERENTIATED LIPOSARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Peking University First Hospital
Beijing, Beijing Municipality, 100034, China
-
Peking University People's Hospital
Beijing, Beijing Municipality, 100044, China
-
Zhongshan Hospital Fudan University
Shanghai, Shanghai Municipality, 200032, China
Conditions
Explore the condition pages connected to this study.